Biallelic mutations in the ATM gene in T-prolymphocytic leukemia

Nature Medicine

Volumn 3, Issue 10, 1997, Pages 1155-1159

  Stilgenbauer, Stephan ^a   Schaffner, Claudia ^b   Litterst, Annette ^a   Liebisch, Peter ^a   Gilad, Shlomit ^c   Bar Shira, Anat ^c   James, Michael R ^d   Lichter, Peter ^b   Döhner, Hartmut ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c TEL AVIV UNIVERSITY   (Israel)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; ATAXIA TELANGIECTASIA; CANCER GENETICS; CHROMOSOME 11Q; CHROMOSOME DELETION; CLINICAL ARTICLE; GENE DELETION; GENE DISRUPTION; GENE MUTATION; HUMAN; MOLECULAR GENETICS; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; T CELL LEUKEMIA; TUMOR SUPPRESSOR GENE;

ALLELES; AMINO ACID SEQUENCE; CELL CYCLE PROTEINS; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; DNA PRIMERS; DNA-BINDING PROTEINS; GENETIC MARKERS; HUMANS; KARYOTYPING; LEUCINE ZIPPERS; LEUKEMIA, PROLYMPHOCYTIC; LEUKEMIA, T-CELL; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEINS;

EID: 0030797830     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1097-1155     Document Type: Article

References (40)

1. Sedgewick, R.P. & Boder, E. Ataxia-telangiectasia. in Handbook of Clinical Neurology, vol. 16 (eds. Vinken, G.B.P. and Klawans, H.) 347-423 (Elsevier Scientific Publishers, New York, 1991).
2. Meyn, M.S. Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res. 55, 5991-6001 (1995).
3. Taylor, A.M.R., Metcalfe, J.A., Thick, J. & Mak, Y.F. Leukemia and lymphoma in ataxia telangiectasia. Blood 87, 423-438 (1996).
4. Savitsky, K. et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268, 1749-1753 (1995).
5. Savitsky, K. et al. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum. Mol. Genet. 4, 2025-2032 (1995).
6. Uziel, T. et al. Genomic organization of the ATM gene. Genomics 33, 317-320 (1996).
7. Chen, G., Lee, E.Y.-H.P. The product of the ATM gene is a 370-kDa nuclear phosphoprotein. J. Biol. Chem. 271, 33693-33697 (1996).
8. Lakin ND. et al. Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene 13, 2707-2716 (1996).
9. Brown, K.D. et al. The ataxia telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage. Proc. Natl. Acad. Sci. USA 94, 1840-1845 (1997).
10. Nowak, R. Discovery of AT gene sparks biomedical research bonanza. Science 268, 1700-1701 (1995).
11. Athma, P., Rappaport, R. & Swift, M. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet. Cytogenet. 92, 130-134 (1996).
12. FitzGerald, M.G. et al. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nature Genet. 15, 307-310 (1997).
13. Vorechovsky, I. et al. The ATM gene and susceptibility to breast cancer: Combined mutation analysis of 38 consecutive breast tumors reveals no evidence for somatic mutations and constitutional AT heterozygosity. Cancer Res. 56, 2726-2732 (1996).
14. Kerangueven, F. et al. Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions. Oncogene 14, 339-347 (1997).
15. Matutes, E. et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 78, 3269-3274 (1991).
16. Harris, N.L. et al. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 84, 1361-1392 (1994).
17. Döhner, H. et al. Pentostatin in prolymphocytic leukemia: Phase II trial of the European organization for research and treatment of cancer leukemia cooperative study group. J. Natl. Cancer Inst. 85, 658-662 (1993).
18. Brito-Babapulle, V., Pomfret, M., Matutes, E. & Catovsky, D. Cytogenetic studies on prolymphocytic leukemia. II. T-cell prolymphocytic leukemia. Blood 70, 926-931 (1987).
19. Finan, J., Daniele, R., Rowlands, D. & Nowell, P. Cytogenetics of chronic T cell leukemia, including two patients with a 14q+ translocation. Virchows Arch. Biol. Cell Pathol. 29, 121-127 (1978).
20. Zech, L. et al. Inversion of chromosome 14 marks human T-cell chronic lymphocytic leukemia. Nature 308, 858-860 (1984).
21. Croce, C.M. et al. Gene for alpha-chain of human T-cell receptor: Location on chromosome 14 region involved in T-cell neoplasms. Science 227, 1044-1047 (1985).
22. Virgilio, L. et al. Identification of the TCL1 gene involved in T-cell malignancies. Proc. Natl. Acad. Sci. USA 91, 12530-12534 (1994).
23. Narducci, M.G. et al. TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia. Blood 86, 2358-2364 (1995).
24. Thick, J. et al. Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients. Oncogene 12, 379-386 (1996).
25. Gilad, S. et al. Predominance of null mutations in ataxia-telangiectasia. Hum. Mol. Genet. 5, 433-439 (1996).
26. Imai, T. et al. Identification and characterization of a new gene physically linked to the ATM gene. Genome Res. 6, 439-447 (1996).
27. Pittman, S., Morilla. R. & Catovsky, D. Chronic T-cell leukemias II. Cytogenetic studies. Leukocyte Res. 6, 33-42 (1982).
28. Hoda Maljaie, S.H. et al. Expression of c-myc oncoprotein in chronic T cell leukemias. Leukemia 9, 1694-1699 (1995).
29. James, M.R. et al. A radiation hybrid map of 506 STS markers spanning human chromosome 11. Nature Genet. 8, 70-76 (1994).
30. Zakian, V.A. ATM-related genes: What do they tell us about function of the human gene? Cell 82, 685-687 (1995).
31. Shafman, T. et al. Interaction between ATM protein and c-Abl in response to DNA damage. Nature 387, 520-523 (1997).
32. Barlow, C. et al. Atm-deficient mice: A paradigm of ataxia telangiectasia. Cell 86, 159-171 (1996).
33. Elson, A. et al. Pleiotropic defects in ataxia-telangiectasia protein deficient mice. Proc. Natl. Acad. Sci. USA 93, 13084-13089 (1996).
34. Xu, Y. et al. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10, 2411-2422 (1996).
35. Lichter, P. et al. High resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 247, 64-69 (1990).
36. Stilgenbauer, S. et al. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11 q22.3-q23.1 in lymphoproliferative disorders. Proc. Natl. Acad. Sci. USA 93, 11837-11841 (1996).
37. Stilgenbauer, S. et al. High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics. Blood 81, 2118-2124 (1993).
38. Herz, J. et al. Surface localization and high affinity for calcium of a 500-kD liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J. 7, 4119-4127 (1988).
39. Van Leuven, F. et al. Structure of the gene (LRP1) coding for the human alpha 2-macroglobulin receptor lipoprotein receptor-related protein. Genomics 24, 78-89 (1994).
40. Beaudet, A.L. & Tsui, L.-C. A suggested nomenclature for designating mutations. Hum. Mutat. 2, 245-248 (1993).